VIVALIS : RESULTAT DES VOTES ASSEMBLEE DES ACTIONNAIRES 12 DECEMBRE 2012
| Source: VALNEVA SE
Recommended Reading
-
Submission based on favorable efficacy and safety results from Phase 3 VALOR trial NEW YORK & LYON, France, August, 14, 2026 Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris:...
Read More -
Valneva Half-Year 2026 Financial Report Attachment Financial Report HY1 2026 (EN) (2026-08-12) (002) ...
Read More